Adcock Ingram Recalls Panado Paediatric Syrup Over Quality Concerns

In a proactive move to maintain product integrity and consumer safety, Adcock Ingram Limited has issued a recall for selected batches of Panado Paediatric alcohol-free grape-flavoured syrup. The recall was initiated after an internal quality control check revealed precipitation in the active ingredient, paracetamol, compromising the syrup's appearance.

The pharmaceutical company alerted that the affected products are packaged in 50ml and 100ml bottles, with expiry dates marked as July 2025, February 2026, and April 2026. Although the visual inconsistency prompted the recall, Adcock Ingram has classified this as a Class III recall, which suggests that the potential health threat posed by the affected syrup is minimal.

Despite the low risk, the company is taking comprehensive steps to ensure public safety. In collaboration with health authorities, Adcock Ingram is efficiently coordinating the withdrawal of the impacted batches from all retailers and pharmacies. Consumers in possession of the syrup from the specified batches are urged to return them to the purchase location for a full refund or exchange.

The firm has issued apologies to its customers for any inconvenience caused by this recall and reaffirms its commitment to stringent quality controls. By adhering to these high standards and recalling the batches that do not meet them, Adcock Ingram reinforces its dedication to consumer safety and the consistent quality of its products.

Parents and guardians who frequently rely on this medication for managing pain and fever in children should check their supplies promptly and follow the recall instructions provided by Adcock Ingram. Moreover, consumers are encouraged to contact the company's customer service for any queries regarding the recall process.

In conclusion, while the recall of Panado Paediatric syrup highlights a significant quality lapse, the prompt response by Adcock Ingram and the minimal health implications assure consumers of the company's responsible approach towards healthcare and consumer welfare.